Exploring the Feasibility of Intrapartum GBS Collection to Identify Residual GBS in a Pilot Study of an Antenatal Probiotic Intervention

(1) Background: We aimed to explore the feasibility of collecting intrapartum maternal Group B Streptococcus (GBS) colonization and immediate post-birth neonatal GBS cultures for use in a larger trial identify cases residual GBS, which were hypothesized be less common probiotics group. (2) Methods: This sub-study added additional outcome measures parent study compare between probiotic placebo groups GBS. Intrapartum vaginal rectal collected at time admission hospital labor give birth. Neonatal oral nasopharynx within 1–2 h giving (3) Results: Thirty samples collected; twenty-eight had complete data. The antepartum results significantly predicted (p = 0.005), with 86.7% remaining same both points. There four where different 36-week results. A case was identified one group participant. None swabs positive No EOGBSD occurred infants born participants. (4) Conclusions: Although 36–37 week results, utility research on reduce antenatal is unclear. swab collection feasible busy nurse, midwife, physician practice. not recovered from nasopharyngeal swabs. pathways require further study.